Heart Failure Treatment Market, Global Outlook and Forecast 2022-2028

February 2022 | 107 pages | ID: H19C6061C12BEN
Market Monitor Global

Abstracts

The main treatment for heart failure is etiological treatment.Because heart failure is the ultimate state of the heart, the causes of heart failure are different.Some people may have hyperthyroidism induced heart failure, and the treatment plan is to actively correct hyperthyroidism.Some people because arrhythmia causes tachycardia, cardiomyopathy, control arrhythmia, heart failure will improve naturally.There are still some people who have heart failure caused by ischemic heart disease. They need coronary angiography to actively change the state of heart ischemia, and heart failure can be recovered to a certain extent.There are other diseases, so the etiology of heart failure is important.If heart failure occurs, take active medication.Above all, want to use the therapeutics of heart failure normatively, strong heart, diuresis, dilate blood-vessel is a few treatment means to heart failure acute period, can alleviate improve the symptom of the patient.Chronic treatment of heart failure requires the long-term use of ACEI or ARB, beta blockers and diuretic drugs to reduce the length of hospital stay in patients with heart failure and improve their quality of life, as well as three-chamber pacemaker implantation and heart transplantation.

This report contains market size and forecasts of Heart Failure Treatment in Global, including the following market information:

Global Heart Failure Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Heart Failure Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Heart Failure Treatment include Pfizer, Novartis, Merck, Sanofi, Johnson & Johnson, AstraZeneca, GlaxoSmithKline, Amgen and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Heart Failure Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Heart Failure Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Heart Failure Treatment Market Segment Percentages, by Type, 2021 (%)

• Drug Treatment
• Surgical Treatment

Global Heart Failure Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Heart Failure Treatment Market Segment Percentages, by Application, 2021 (%)

• Acute Heart Failure
• Chronic Heart Failure

Global Heart Failure Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Heart Failure Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Heart Failure Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Heart Failure Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Novartis
• Merck
• Sanofi
• Johnson & Johnson
• AstraZeneca
• GlaxoSmithKline
• Amgen
• Bayer
• BMS
• Cardiorentis
• Cytokinetics
• Ono Pharmaceuticals
• Mylan
• NCPC
• Xinhua Group
• Xudong Haipu Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Heart Failure Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Heart Failure Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEART FAILURE TREATMENT OVERALL MARKET SIZE

2.1 Global Heart Failure Treatment Market Size: 2021 VS 2028
2.2 Global Heart Failure Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Heart Failure Treatment Players in Global Market
3.2 Top Global Heart Failure Treatment Companies Ranked by Revenue
3.3 Global Heart Failure Treatment Revenue by Companies
3.4 Top 3 and Top 5 Heart Failure Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Heart Failure Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Heart Failure Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Heart Failure Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Heart Failure Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Heart Failure Treatment Market Size Markets, 2021 & 2028
  4.1.2 Drug Treatment
  4.1.3 Surgical Treatment
4.2 By Type - Global Heart Failure Treatment Revenue & Forecasts
  4.2.1 By Type - Global Heart Failure Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Heart Failure Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Heart Failure Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Heart Failure Treatment Market Size, 2021 & 2028
  5.1.2 Acute Heart Failure
  5.1.3 Chronic Heart Failure
5.2 By Application - Global Heart Failure Treatment Revenue & Forecasts
  5.2.1 By Application - Global Heart Failure Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Heart Failure Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Heart Failure Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Heart Failure Treatment Market Size, 2021 & 2028
6.2 By Region - Global Heart Failure Treatment Revenue & Forecasts
  6.2.1 By Region - Global Heart Failure Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Heart Failure Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Heart Failure Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Heart Failure Treatment Revenue, 2017-2028
  6.3.2 US Heart Failure Treatment Market Size, 2017-2028
  6.3.3 Canada Heart Failure Treatment Market Size, 2017-2028
  6.3.4 Mexico Heart Failure Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Heart Failure Treatment Revenue, 2017-2028
  6.4.2 Germany Heart Failure Treatment Market Size, 2017-2028
  6.4.3 France Heart Failure Treatment Market Size, 2017-2028
  6.4.4 U.K. Heart Failure Treatment Market Size, 2017-2028
  6.4.5 Italy Heart Failure Treatment Market Size, 2017-2028
  6.4.6 Russia Heart Failure Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Heart Failure Treatment Market Size, 2017-2028
  6.4.8 Benelux Heart Failure Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Heart Failure Treatment Revenue, 2017-2028
  6.5.2 China Heart Failure Treatment Market Size, 2017-2028
  6.5.3 Japan Heart Failure Treatment Market Size, 2017-2028
  6.5.4 South Korea Heart Failure Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Heart Failure Treatment Market Size, 2017-2028
  6.5.6 India Heart Failure Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Heart Failure Treatment Revenue, 2017-2028
  6.6.2 Brazil Heart Failure Treatment Market Size, 2017-2028
  6.6.3 Argentina Heart Failure Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Heart Failure Treatment Revenue, 2017-2028
  6.7.2 Turkey Heart Failure Treatment Market Size, 2017-2028
  6.7.3 Israel Heart Failure Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Heart Failure Treatment Market Size, 2017-2028
  6.7.5 UAE Heart Failure Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Heart Failure Treatment Major Product Offerings
  7.1.4 Pfizer Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Heart Failure Treatment Major Product Offerings
  7.2.4 Novartis Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Heart Failure Treatment Major Product Offerings
  7.3.4 Merck Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.3.5 Merck Key News
7.4 Sanofi
  7.4.1 Sanofi Corporate Summary
  7.4.2 Sanofi Business Overview
  7.4.3 Sanofi Heart Failure Treatment Major Product Offerings
  7.4.4 Sanofi Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.4.5 Sanofi Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Heart Failure Treatment Major Product Offerings
  7.5.4 Johnson & Johnson Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 AstraZeneca
  7.6.1 AstraZeneca Corporate Summary
  7.6.2 AstraZeneca Business Overview
  7.6.3 AstraZeneca Heart Failure Treatment Major Product Offerings
  7.6.4 AstraZeneca Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.6.5 AstraZeneca Key News
7.7 GlaxoSmithKline
  7.7.1 GlaxoSmithKline Corporate Summary
  7.7.2 GlaxoSmithKline Business Overview
  7.7.3 GlaxoSmithKline Heart Failure Treatment Major Product Offerings
  7.7.4 GlaxoSmithKline Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.7.5 GlaxoSmithKline Key News
7.8 Amgen
  7.8.1 Amgen Corporate Summary
  7.8.2 Amgen Business Overview
  7.8.3 Amgen Heart Failure Treatment Major Product Offerings
  7.8.4 Amgen Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.8.5 Amgen Key News
7.9 Bayer
  7.9.1 Bayer Corporate Summary
  7.9.2 Bayer Business Overview
  7.9.3 Bayer Heart Failure Treatment Major Product Offerings
  7.9.4 Bayer Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.9.5 Bayer Key News
7.10 BMS
  7.10.1 BMS Corporate Summary
  7.10.2 BMS Business Overview
  7.10.3 BMS Heart Failure Treatment Major Product Offerings
  7.10.4 BMS Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.10.5 BMS Key News
7.11 Cardiorentis
  7.11.1 Cardiorentis Corporate Summary
  7.11.2 Cardiorentis Business Overview
  7.11.3 Cardiorentis Heart Failure Treatment Major Product Offerings
  7.11.4 Cardiorentis Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.11.5 Cardiorentis Key News
7.12 Cytokinetics
  7.12.1 Cytokinetics Corporate Summary
  7.12.2 Cytokinetics Business Overview
  7.12.3 Cytokinetics Heart Failure Treatment Major Product Offerings
  7.12.4 Cytokinetics Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.12.5 Cytokinetics Key News
7.13 Ono Pharmaceuticals
  7.13.1 Ono Pharmaceuticals Corporate Summary
  7.13.2 Ono Pharmaceuticals Business Overview
  7.13.3 Ono Pharmaceuticals Heart Failure Treatment Major Product Offerings
  7.13.4 Ono Pharmaceuticals Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.13.5 Ono Pharmaceuticals Key News
7.14 Mylan
  7.14.1 Mylan Corporate Summary
  7.14.2 Mylan Business Overview
  7.14.3 Mylan Heart Failure Treatment Major Product Offerings
  7.14.4 Mylan Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.14.5 Mylan Key News
7.15 NCPC
  7.15.1 NCPC Corporate Summary
  7.15.2 NCPC Business Overview
  7.15.3 NCPC Heart Failure Treatment Major Product Offerings
  7.15.4 NCPC Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.15.5 NCPC Key News
7.16 Xinhua Group
  7.16.1 Xinhua Group Corporate Summary
  7.16.2 Xinhua Group Business Overview
  7.16.3 Xinhua Group Heart Failure Treatment Major Product Offerings
  7.16.4 Xinhua Group Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.16.5 Xinhua Group Key News
7.17 Xudong Haipu Pharmaceutical
  7.17.1 Xudong Haipu Pharmaceutical Corporate Summary
  7.17.2 Xudong Haipu Pharmaceutical Business Overview
  7.17.3 Xudong Haipu Pharmaceutical Heart Failure Treatment Major Product Offerings
  7.17.4 Xudong Haipu Pharmaceutical Heart Failure Treatment Revenue in Global Market (2017-2022)
  7.17.5 Xudong Haipu Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Heart Failure Treatment Market Opportunities & Trends in Global Market
Table 2. Heart Failure Treatment Market Drivers in Global Market
Table 3. Heart Failure Treatment Market Restraints in Global Market
Table 4. Key Players of Heart Failure Treatment in Global Market
Table 5. Top Heart Failure Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Heart Failure Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Heart Failure Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Heart Failure Treatment Product Type
Table 9. List of Global Tier 1 Heart Failure Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Heart Failure Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Heart Failure Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Heart Failure Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Heart Failure Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Heart Failure Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Heart Failure Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Heart Failure Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Heart Failure Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Heart Failure Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Heart Failure Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Heart Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Heart Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Heart Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Heart Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Heart Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Heart Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Heart Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Heart Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Heart Failure Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Heart Failure Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Heart Failure Treatment Product Offerings
Table 32. Pfizer Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Heart Failure Treatment Product Offerings
Table 35. Novartis Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Heart Failure Treatment Product Offerings
Table 38. Merck Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Heart Failure Treatment Product Offerings
Table 41. Sanofi Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Heart Failure Treatment Product Offerings
Table 44. Johnson & Johnson Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Heart Failure Treatment Product Offerings
Table 47. AstraZeneca Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 48. GlaxoSmithKline Corporate Summary
Table 49. GlaxoSmithKline Heart Failure Treatment Product Offerings
Table 50. GlaxoSmithKline Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Amgen Corporate Summary
Table 52. Amgen Heart Failure Treatment Product Offerings
Table 53. Amgen Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Bayer Corporate Summary
Table 55. Bayer Heart Failure Treatment Product Offerings
Table 56. Bayer Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 57. BMS Corporate Summary
Table 58. BMS Heart Failure Treatment Product Offerings
Table 59. BMS Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Cardiorentis Corporate Summary
Table 61. Cardiorentis Heart Failure Treatment Product Offerings
Table 62. Cardiorentis Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Cytokinetics Corporate Summary
Table 64. Cytokinetics Heart Failure Treatment Product Offerings
Table 65. Cytokinetics Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Ono Pharmaceuticals Corporate Summary
Table 67. Ono Pharmaceuticals Heart Failure Treatment Product Offerings
Table 68. Ono Pharmaceuticals Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Mylan Corporate Summary
Table 70. Mylan Heart Failure Treatment Product Offerings
Table 71. Mylan Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 72. NCPC Corporate Summary
Table 73. NCPC Heart Failure Treatment Product Offerings
Table 74. NCPC Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Xinhua Group Corporate Summary
Table 76. Xinhua Group Heart Failure Treatment Product Offerings
Table 77. Xinhua Group Heart Failure Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Xudong Haipu Pharmaceutical Corporate Summary
Table 79. Xudong Haipu Pharmaceutical Heart Failure Treatment Product Offerings
Table 80. Xudong Haipu Pharmaceutical Heart Failure Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Heart Failure Treatment Segment by Type in 2021
Figure 2. Heart Failure Treatment Segment by Application in 2021
Figure 3. Global Heart Failure Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Heart Failure Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Heart Failure Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Heart Failure Treatment Revenue in 2021
Figure 8. By Type - Global Heart Failure Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Heart Failure Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Heart Failure Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Heart Failure Treatment Revenue Market Share, 2017-2028
Figure 12. US Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Heart Failure Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Heart Failure Treatment Revenue Market Share, 2017-2028
Figure 24. China Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Heart Failure Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Heart Failure Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Heart Failure Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. GlaxoSmithKline Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Amgen Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bayer Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. BMS Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Cardiorentis Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cytokinetics Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Ono Pharmaceuticals Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Mylan Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. NCPC Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Xinhua Group Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Xudong Haipu Pharmaceutical Heart Failure Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)